Merck & Co said on Thursday that it plans to launch a subcutaneously injected version of its blockbuster cancer immunotherapy ...

Merck has signed a licensing deal with Jiangsu Hengrui Pharmaceuticals worth up to $2 billion for its experimental heart ...

A federal judge ruled in favor of Merck in litigation accusing it of concealing the risks of Gardasil, a vaccine to prevent ...

Merck said on Tuesday it has opened a $1-billion facility at its North Carolina site, the latest drugmaker to boost its U.S. manufacturing amid President Donald Trump's tariff threats.

March 5 (Reuters) - Merck's (MRK.N), opens new tab injected version of its blockbuster cancer drug Keytruda could face a potential patent challenge from biotech Halozyme Therapeutics (HALO.O ...

Drugmakers are urging the Trump administration and European Union officials to exclude medical goods from expanding tariff ...

FRANKFURT, March 6 (Reuters) - Merck KGaA (MRCG.DE), opens new tab on Thursday forecast currency-adjusted operating earnings growth of up to 8%, helped by demand for semiconductor chemicals and ...

REUTERS/Andrew Kelly/File Photo Denmark's Bavarian ... 2025 Healthcare & Pharmaceuticalscategory Merck plans to launch US subcutaneous version of Keytruda on October 1 March 28, 2025 Healthcare ...